Edwards Lifesciences Corporation
86.18USD
-0.5400 (-0.62%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.74▼ | $0.74 | 2 | 15 |
| Next quarter | $0.71▼ | $0.74 | 0 | 22 |
| Current year | $3▼ | $3.01 | 6 | 14 |
| Next year | $3.38▲ | $3.37 | 17 | 6 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.74 | $0.78 | +0.04 (+5.1%) |
| 2026-03-31 | $0.73 | $0.78 | +0.05 (+7.3%) |
| 2025-12-31 | $0.62 | $0.58 | -0.04 (-6.3%) |
| 2025-09-30 | $0.59 | $0.67 | +0.08 (+12.6%) |
504 ratings from 42 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Leerink Partners | Upgraded from Market Perform | Outperform | $87 $101 | Jul 25, 2026 |
| JP Morgan | Maintained | Overweight | $100 $105 | Jul 24, 2026 |
| Piper Sandler | Reiterated | Overweight | $100 $101 | Jul 24, 2026 |
| Truist Securities | Maintained | Hold | $90 $95 | Jul 16, 2026 |
| Mizuho | Maintained | Outperform | $100 $105 | Jul 15, 2026 |
| RBC Capital | Maintained | Outperform | $100 $110 | Jul 13, 2026 |
| Citigroup | Maintained | Buy | $101 $110 | Jul 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $93 $100 | Jul 6, 2026 |
| BTIG | Maintained | Buy | $100 $110 | Jun 30, 2026 |
| RBC Capital | Reiterated | Outperform | $100 | Jun 16, 2026 |
| TD Cowen | Maintained | Buy | $97 $104 | Jun 2, 2026 |
| Barclays | Maintained | Overweight | $104 $110 | Apr 27, 2026 |
| Evercore ISI Group | Maintained | Outperform | $92 $93 | Apr 24, 2026 |
| Truist Securities | Maintained | Hold | $89 $90 | Apr 24, 2026 |
| Canaccord Genuity | Maintained | Hold | $87 $85 | Apr 24, 2026 |
| BTIG | Maintained | Buy | $98 $100 | Apr 24, 2026 |
| Baird | Maintained | Neutral | $85 $87 | Apr 24, 2026 |
| Mizuho | Maintained | Outperform | $100 $95 | Apr 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $94 $92 | Apr 6, 2026 |
| Goldman Sachs | Maintained | Buy | $108 $95 | Feb 11, 2026 |
| Piper Sandler | Reiterated | Overweight | $98 $100 | Feb 11, 2026 |
| Truist Securities | Maintained | Hold | $92 $89 | Feb 11, 2026 |
| Wells Fargo | Maintained | Overweight | $96 $100 | Feb 11, 2026 |
| BTIG | Reiterated | Buy | $103 | Feb 11, 2026 |
| Stifel | Maintained | Buy | $105 $110 | Jan 20, 2026 |
155 filings from 19 insiders · 37 buy / 24 sell over 6m
Officers and directors of EW, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Dahl Andrew M.Officer, SVP, Corporate Controller | Sell | 544 | $91.06 | $50k | Aug 31, 2026 |
| BRULS ANNETTEOfficer | Sell | 2.6k | $89.98 | $238k | Aug 28, 2026 |
| CHOPRA DAVEENOfficer | Exercise | 31.8k | $72.68 | $2.31M | Aug 26, 2026 |
| MARKOWITZ WAYNEOfficer | Sell | 1.2k | $91.46 | $113k | Aug 26, 2026 |
| CHOPRA DAVEENOfficer | Sell | 31.8k | $90.99 | $2.89M | Aug 26, 2026 |
| LIPPIS DANIEL JOfficer | Sell | 619 | $92.03 | $57k | Aug 11, 2026 |
| LIPPIS DANIEL JOfficer | Exercise | 619 | $72.68 | $45k | Aug 11, 2026 |
| MARKOWITZ WAYNEOfficer | Sell | 146 | $86.03 | $13k | Jul 30, 2026 |
| MARKOWITZ WAYNEOfficer | Sell | 9.6k | $85.06 | $819k | Jul 28, 2026 |
| MARKOWITZ WAYNEOfficer | Exercise | 9.6k | $74.02 | $713k | Jul 28, 2026 |
| ZOVIGHIAN BERNARD JChief Executive Officer | Sellindirect | 2.9k | $83.93 | $245k | Jul 27, 2026 |
| ZOVIGHIAN BERNARD JChief Executive Officer | Gift | 319 | — | — | Jul 27, 2026 |
| LIPPIS DANIEL JOfficer | Sell | 619 | $91.70 | $57k | Jul 10, 2026 |
| LIPPIS DANIEL JOfficer | Exercise | 619 | $72.68 | $45k | Jul 10, 2026 |
| MISTRAS THEODORAChief Financial Officer | Grant | 99.9k | — | — | Jul 9, 2026 |
| LIPPIS DANIEL JOfficer | Sell | 619 | $91.40 | $57k | Jun 30, 2026 |
| LIPPIS DANIEL JOfficer | Exercise | 619 | $72.68 | $45k | Jun 30, 2026 |
| ZOVIGHIAN BERNARD JChief Executive Officer | Sellindirect | 523 | $87.92 | $46k | Jun 17, 2026 |
| DAHL ANDREW MOfficer | Sell | 567 | $86.08 | $49k | May 29, 2026 |
| BOBO DONALD E JROfficer | Sellindirect | 23.1k | $86.42 | $2.00M | May 27, 2026 |
No analyst notes on EW yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 18 | 7 | 0 | 0 | Buy2.10 |
| 1 mo ago | 4 | 18 | 7 | 0 | 0 | Buy2.10 |
| 2 mo ago | 4 | 18 | 7 | 0 | 0 | Buy2.10 |
| 3 mo ago | 4 | 17 | 8 | 0 | 0 | Buy2.14 |